Phase II Trial of In Vivo Purging with Daratumumab in Newly Diagnosed Multiple Myeloma
Year: 2020
Type: article
Study design: Study Protocol
Source: Blood
Institution: Levine Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096754565
